Richard K Haynes

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 17

Top Venues

Pharmaceutics

Pathogens (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Methods and protocols

North-West University

University of Western Australia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

North-West University

South Africa

Research Professor :: Centre of Excellence for Pharmaceutical Sciences

Hong Kong University of Science and Technology Jul 01 2011

Hong Kong

Adjunct Professor :: Department of Chemistry

North-West University Oct 01 2011 - Sep 30 2012

South Africa

Visiting Professor :: Division of Science and Technology/Preclinical Drug Development Platform

Hong Kong University of Science and Technology Jan 15 1993 - Jun 30 2011

Hong Kong

Professor :: Department of Chemistry

University of Sydney Aug 01 1978 - Dec 31 1992

Australia

Lecturer/Senior Lecturer/Reader :: Department of Organic Chemistry

Monash University Feb 01 1975 - Jul 31 1978

Australia

Senior Tutor :: Department of Chemistry

Education History

University of Western Australia Feb 01 1967 - Nov 30 1969

Australia

PHD :: Department of Chemistry

University of Western Australia Feb 01 1963 - Nov 30 1966

Australia

BSC :: Department of Chemistry

Publications

Jessica Ramseier, Dennis Imhof, Kai Pascal Alexander Hänggeli, Nicoleta Anghel, Ghalia Boubaker, Richard M Beteck, Luis-Miguel Ortega-Mora, Richard K Haynes, Andrew Hemphill
In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline- O -Carbamate Derivatives against Experimental Infection with Neospora caninum Tachyzoites. Pathogens (Basel, Switzerland) 12 (3) (2023)
Daniélle van Staden, Richard K Haynes, Frank Van der Kooy, Joe M Viljoen
Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System. Methods and protocols 6 (6) (2023)
Jessica Ramseier, Dennis Imhof, Kai Pascal Alexander Hänggeli, Nicoleta Anghel, Ghalia Boubaker, Richard M Beteck, Luis-Miguel Ortega-Mora, Richard K Haynes, Andrew Hemphill
In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline- O -Carbamate Derivatives against Experimental Infection with Neospora caninum Tachyzoites. Pathogens (Basel, Switzerland) 12 (3) (2023)
Jessica Ramseier, Dennis Imhof, Kai Pascal Alexander Hänggeli, Nicoleta Anghel, Ghalia Boubaker, Richard M Beteck, Luis-Miguel Ortega-Mora, Richard K Haynes, Andrew Hemphill
In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline- O -Carbamate Derivatives against Experimental Infection with Neospora caninum Tachyzoites. Pathogens (Basel, Switzerland) 12 (3) (2023)
Daniélle van Staden, Richard K Haynes, Joe M Viljoen
The Development of Dermal Self-Double-Emulsifying Drug Delivery Systems: Preformulation Studies as the Keys to Success. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Daniélle van Staden, Richard K Haynes, Joe M Viljoen
The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems. Pharmaceutics 15 (4) (2023)
Daniélle van Staden, Richard K Haynes, Joe M Viljoen
The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems. Pharmaceutics 15 (4) (2023)
Daniélle van Staden, Richard K Haynes, Joe M Viljoen
The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems. Pharmaceutics 15 (4) (2023)
Daniélle van Staden, Richard K Haynes, Joe M Viljoen
The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems. Pharmaceutics 15 (4) (2023)
Francesca Sisto, Simone Carradori, Sarah D'Alessandro, Nadia Santo, Norma Lattuada, Richard K Haynes, Donatella Taramelli, Rossella Grande
In Vitro Activity of the Arylaminoartemisinin GC012 against Helicobacter pylori and Its Effects on Biofilm. Pathogens (Basel, Switzerland) 11 (7) (2022)
Daniélle van Staden, Richard K Haynes, Joe M Viljoen
Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Jessica Ramseier, Dennis Imhof, Nicoleta Anghel, Kai Hänggeli, Richard M Beteck, Vreni Balmer, Luis-Miguel Ortega-Mora, Roberto Sanchez-Sanchez, Ignacio Ferre, Richard K Haynes, Andrew Hemphill
Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts. Molecules (Basel, Switzerland) 26 (21) (2021)
Paolo Coghi, Li Jun Yang, Jerome P L Ng, Richard K Haynes, Maurizio Memo, Alessandra Gianoncelli, Vincent Kam Wai Wong, Giovanni Ribaudo
A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2). Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Monalisa Roy, Keyao Li, Madiha Nisar, Lawrence W-Y Wong, Herman Ho-Yung Sung, Richard K Haynes, Ian D Williams
Varying degrees of homostructurality in a series of cocrystals of antimalarial drug 11-azaartemisinin with salicylic acids. Acta crystallographica. Section C, Structural chemistry 77 (Pt 6) (2021)
Liezl Gibhard, Dina Coertzen, Janette Reader, Mariëtte E van der Watt, Lyn-Marié Birkholtz, Ho Ning Wong, Kevin T Batty, Richard K Haynes, Lubbe Wiesner
The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside. Pharmaceutics 13 (12) (2021)
Lloyd Tanner, Gabriel T Mashabela, Charles C Omollo, Timothy J de Wet, Christopher J Parkinson, Digby Francis Warner, Richard K Haynes, Lubbe Wiesner
Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy. Microbiology spectrum 9 (2) (2021)
Lloyd Tanner, Joanna C Evans, Ronnett Seldon, Audrey Jordaan, Digby Francis Warner, Richard K Haynes, Christopher J Parkinson, Lubbe Wiesner
In Vitro Efficacies, ADME, and Pharmacokinetic Properties of Phenoxazine Derivatives Active against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 63 (11) (2019)

Richard K Haynes.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Richard K Haynes